MIRA Pharmaceuticals, Inc.
MIRA
$0.9389
-$0.1311-12.25%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -17.41% | -20.85% | 1.54% | 70.32% | -61.31% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -266.66% |
| Total Other Non-Cash Items | 103.27% | -55.52% | 20.91% | -91.34% | 304.56% |
| Change in Net Operating Assets | 171.17% | -130.23% | 32.50% | 158.25% | -624.62% |
| Cash from Operations | 2.01% | -113.23% | 17.68% | -1.40% | 41.24% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 200.00% | -159.67% | 200.00% | 97.59% | -- |
| Issuance of Common Stock | -84.70% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -100.00% | -64.59% | -- | -- | 98.68% |
| Cash from Financing | -84.40% | 1,889.25% | 754.32% | 89.47% | -103.03% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -199.30% | 287.37% | 34.36% | 15.16% | -121.66% |